Effect of platelet-rich plasma (PRP) on ovarian structures in cyclophosphamide-induced ovarian failure in female rats: a stereological study

References

• Ataya KM, Pydyn EF, Ramahi-Ataya AJ. 1990. The effect of “activated” cyclophosphamide on human and rat ovarian granulosa cells in vitro. Reprod Toxicol. 4:121–125.
   PubMed Web of Science ®Google Scholar
• Bordbar H, Mesbah F, Talaei T, Dehghani F, Mirkhani H. 2014. Modulatory effect of gonadotropins on rats’ ovaries after nandrolone decanoate administration: a stereological study. Iran J Med Sci. 39:44–50.
   PubMedGoogle Scholar
• Budel V, Kiss R, De Launoit Y, Danguy A, Atassi G, Pasteels J, Paridaens R. 1988. Prevention of ovarian damage induced by cyclophosphamide in adult female mice by hormonal manipulations. J Reprod Fertil. 84:625–633.
   PubMedGoogle Scholar
• Comish PB, Drumond AL, Kinnell HL, Anderson RA, Matin A, Meistrich ML, Shetty G. 2014. Fetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in mice. PLoS One. 9:e93311.
   PubMed Web of Science ®Google Scholar
• de Castro FC, Cruz MHC, Leal CLV. 2016. Role of growth differentiation factor 9 and bone morphogenetic protein 15 in ovarian function and their importance in mammalian female fertility—a review. Asian-Australas J Anim Sci. 29:1065–1074.
   PubMed Web of Science ®Google Scholar
• Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM. 1996. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature. 383:531–535.
   PubMed Web of Science ®Google Scholar
• Ebrahimi M, Asbagh FA. 2011. Pathogenesis and causes of premature ovarian failure: an update. Int J Fertil Steril. 5:54–65.
   PubMed Web of Science ®Google Scholar
• Emori C, Sugiura K. 2014. Role of oocyte-derived paracrine factors in follicular development. Anim Sci J. 85:627–633.
   PubMed Web of Science ®Google Scholar
• Epstein RJ. 1990. Drug-induced DNA damage and tumor chemosensitivity. J Clin Oncol. 8:2062–2084.
   PubMed Web of Science ®Google Scholar
• Hafen E, Stocker H. 2003. How are the sizes of cells, organs, and bodies controlled? PLoS Biol. 1:E86.
   PubMed Web of Science ®Google Scholar
• Haubitz M. 2007. Acute and long-term toxicity of cyclophosphamide. Transplantationsmedizin. 19:26–31.
   Google Scholar
• Hillier SG. 2009. Paracrine support of ovarian stimulation. Mol Hum Reprod. 15:843–850.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhao J, Qi H-J, Li X-L, Zhang S-R, Song DW, Yu C-Y, Gao J-G. 2013. Accelerated ovarian aging in mice by treatment of busulfan and cyclophosphamide. J Zhejiang Univ Sci B. 14:318–324.
   PubMed Web of Science ®Google Scholar
• Lin J-X, Jia Y-D, Zhang C-Q. 2011. Effect of epidermal growth factor on follicle-stimulating hormone-induced proliferation of granulosa cells from chicken prehierarchical follicles. J Zhejiang Univ Sci B. 12:875–883.
   PubMed Web of Science ®Google Scholar
• Lloyd AC. 2013. The regulation of cell size. Cell. 154:1194–1205.
   PubMed Web of Science ®Google Scholar
• Lopez SG, Luderer U. 2004. Effects of cyclophosphamide and buthionine sulfoximine on ovarian glutathione and apoptosis. Free Radic Biol Med. 36:1366–1377.
   PubMed Web of Science ®Google Scholar
• Lubkowska A, Dolegowska B, Banfi G. 2012. Growth factor content in PRP and their applicability in medicine. J Biol Regul Homeost Agents. 26:3S–22S.
   PubMedGoogle Scholar
• Mafi A, Dehghani F, Moghadam A, Noorafshan A, Vojdani Z, Talaei-Khozani T. 2016. Effects of platelet-rich plasma on liver regeneration in CCl4-induced hepatotoxicity model. Platelets. 27:771–776.
   PubMed Web of Science ®Google Scholar
• Mandarim-de-Lacerda CA. 2003. Stereological tools in biomedical research. An Acad Bras Cienc. 75:469–486.
   PubMed Web of Science ®Google Scholar
• Meirow D, Assad G, Dor J, Rabinovici J. 2004. The GnRH antagonist cetrorelix reduces cyclophosphamide‐induced ovarian follicular destruction in mice. Hum Reprod. 19:1294–1299.
   PubMed Web of Science ®Google Scholar
• Mendes FA, Aguiar JMC, Kahn SA, Reis AH, Dubois LG, Romão LF, Ferreira LS, Chneiweiss H, Neto VM, Abreu JG. 2015. Connective-tissue growth factor (CTGF/CCN2) induces astrogenesis and fibronectin expression of embryonic neural cells in vitro. PloS One. 10:e0133689.
   PubMed Web of Science ®Google Scholar
• Nagashima T, Kim J, Li Q, Lydon JP, DeMayo FJ, Lyons KM, Matzuk MM. 2011. Connective tissue growth factor is required for normal follicle development and ovulation. Mol Endocrinol. 25:1740–1759.
   PubMedGoogle Scholar
• Nicosia SV, Matus ‐Ridley M, Meadows AT. 1985. Gonadal effects of cancer therapy in girls. Cancer. 55:2364–2372.
   PubMed Web of Science ®Google Scholar
• Pintat J, Silvestre A, Magalon G, Gadeau AP, Pesquer L, Perozziello A, Peuchant A, Mounayer C, Dallaudière B. 2017. Intra-articular injection of mesenchymal stem cells and platelet-rich plasma to treat patellofemoral osteoarthritis: preliminary results of a long-term pilot study. J Vasc Interv Radiol. 28:1708–1713.
   PubMed Web of Science ®Google Scholar
• Ramahi-Ataya AJ, Ataya KM, Subramanian MG, Struck RF. 1988. The effect of “activated” cyclophosphamide on rat granulosa cells in vitro. Reprod Toxicol. 2:99–103.
   PubMedGoogle Scholar
• Su Y-Q, Sugiura K, Wigglesworth K, O'Brien MJ, Affourtit JP, Pangas SA, Matzuk MM, Eppig JJ. 2008. Oocyte regulation of metabolic cooperativity between mouse cumulus cells and oocytes: BMP15 and GDF9 vehicle cholesterol biosynthesis in cumulus cells. Development. 135:111–121.
   PubMed Web of Science ®Google Scholar
• Thomas FH, Vanderhyden BC. 2006. Oocyte-granulosa cell interactions during mouse follicular development: regulation of kit ligand expression and its role in oocyte growth. Reprod Biol Endocrinol. 4:19.
   PubMed Web of Science ®Google Scholar
• Tobita M, Tajima S, Mizuno H. 2015. Adipose tissue-derived mesenchymal stem cells and platelet-rich plasma: stem cell transplantation methods that enhance stemness. Stem Cell Res Ther. 6:215.
   PubMed Web of Science ®Google Scholar
• Uhm S, Gupta M, Yang J, Chung H-J, Min T, Lee H. 2010. Epidermal growth factor can be used in lieu of follicle-stimulating hormone for nuclear maturation of porcine oocytes in vitro. Theriogenology. 73:1024–1036.
   PubMed Web of Science ®Google Scholar
• Warne G, Fairley K, Hobbs JB, Martin F. 1973. Cyclophosphamide-induced ovarian failure. N Engl J Med. 289:1159–1162.
   PubMed Web of Science ®Google Scholar
• Yan C, Wang P, DeMayo J, DeMayo FJ, Elvin JA, Carino C, Prasad SV, Skinner SS, Dunbar BS, Dube JL, et al. 2001. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol. 15:854–866.
   PubMed Web of Science ®Google Scholar
• Zetterberg A, Engström W, Dafgård E. 1984. The relative effects of different types of growth factors on DNA replication, mitosis, and cellular enlargement. Cytometry Part A. 5:368–375.
   Google Scholar